Stock GLTO GALECTO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Galecto, Inc.

Equities

GLTO

US36322Q1076

Market Closed - Nasdaq
Other stock markets
 21:00:00 26/06/2024 BST 		5-day change 1st Jan Change
0.49 USD -0.24% Intraday chart for Galecto, Inc. -0.26% -31.94%
06-10 Oppenheimer Adjusts Price Target on Galecto to $9 From $10, Maintains Outperform Rating MT
05-01 Galecto, Inc. Announces First Patient Dosed in an Investigator-Initiated Phase 2 Trial of GB1211 in Combination with Pembrolizumab CI

Evolution of the average Target Price on Galecto, Inc.

Price target over the last 5 years

History of analyst recommendation changes

47fe5dd70193b2653cb7a2a.loxDMBg8ZvoM-yVnuK4uFwxxxpaIsLlnhGw3dWRkKew.2PsZYX4IDoJYnWce3JpoJFwc8_Xe0fQo5lhUJg0oXIni4S4IaEgTnHiSYA~d29ead499039766a5b3667782017b53a

Analyst Recommendations on Galecto, Inc.

Oppenheimer Adjusts Price Target on Galecto to $9 From $10, Maintains Outperform Rating MT
HC Wainwright Downgrades Galecto to Neutral From Buy MT
HC Wainwright Adjusts Price Target on Galecto to $2 From $12, Maintains Buy Rating MT
Oppenheimer Initiates Coverage on Galecto With Outperform Rating, $12 Price Target MT
Cantor Fitzgerald Initiates Galecto at Overweight With $16 Price Target MT
SVB Securities Adjusts Galecto's Price Target to $13 from $16, Keeps Outperform Rating MT
Credit Suisse Trims Galecto's Price Target to $6 from $7, Maintains Outperform Rating MT
GALECTO : Credit Suisse Lowers Galecto's PT to $7 from $12 on Lower Projected Sales for GB0139, Reduced Near-Term M&A Expectations; Keeps Outperform Rating MT
GALECTO : Credit Suisse Lowers Galecto's PT to $12 from $29 After Recommendation to End Parts of GB0139 Phase 2 Study, Keeps Outperform Rating MT
GALECTO : SVB Leerink Adjusts Galecto's Price Target to $16 From $27, Keeps Outperform Rating MT
GALECTO : Credit Suisse Initiates Coverage on Galecto With Outperform Rating, $29 Price Target MT
GALECTO : BofA Securities Initiates Coverage on Galecto With Buy Rating, $21 Price Target MT
GALECTO : SVB Leerink Starts Galecto at Outperform With $27 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
0.49 USD
Average target price
5.5 USD
Spread / Average Target
+1,022.45%
High Price Target
9 USD
Spread / Highest target
+1,736.73%
Low Price Target
2 USD
Spread / Lowest Target
+308.16%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Galecto, Inc.

Oppenheimer
HC Wainwright
Cantor Fitzgerald
SVB Securities LLC
Credit Suisse
SVB Leerink

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. GLTO Stock
  4. Consensus Galecto, Inc.